Federated Hermes
VYGR icon

Federated Hermes’s Voyager Therapeutics VYGR Stock Holding History

Federated Hermes’s Portfolio VYGR Stock Details VYGR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-317
Closed -$986 – 2247
2025
Q2 		$986 Buy
+317
New +$1.02K ﹤0.01% 2001
2024
Q4 		– Sell
-551,398
Closed -$3.23M – 2199
2024
Q3 		$3.23M Sell
551,398
-2,816
-0.5% -$20.5K 0.01% 826
2024
Q2 		$4.38M Buy
554,214
+2,638
+0.5% +$22.1K 0.01% 743
2024
Q1 		$5.14M Hold
551,576
– – 0.01% 723
2023
Q4 		$4.66M Sell
551,576
-32,309
-6% -$234K 0.01% 749
2023
Q3 		$4.53M Sell
583,885
-4,403
-0.7% -$40.2K 0.01% 720
2023
Q2 		$6.74M Sell
588,288
-17,330
-3% -$179K 0.02% 633
2023
Q1 		$4.67M Sell
605,618
-41
-0% -$326 0.01% 721
2022
Q4 		$3.69M Sell
605,659
-136
-0% -$773 0.01% 744
2022
Q3 		$3.59M Sell
605,795
-7,252
-1% -$46.4K 0.01% 746
2022
Q2 		$3.62M Sell
613,047
-12,034
-2% -$81.3K 0.01% 771
2022
Q1 		$4.76M Sell
625,081
-259
-0% -$1.16K 0.01% 794
2021
Q4 		$1.7M Sell
625,340
-94,108
-13% -$321K ﹤0.01% 1096
2021
Q3 		$1.89M Buy
719,448
+41,123
+6% +$134K ﹤0.01% 1060
2021
Q2 		$2.8M Buy
678,325
+404,893
+148% +$1.83M 0.01% 994
2021
Q1 		$1.29M Sell
273,432
-35,731
-12% -$244K ﹤0.01% 1278
2020
Q4 		$2.21M Sell
309,163
-215
-0.1% -$2.07K ﹤0.01% 1025
2020
Q3 		$3.3M Buy
309,378
+49,435
+19% +$580K 0.01% 835
2020
Q2 		$3.28M Sell
259,943
-217,915
-46% -$2.53M 0.01% 830
2020
Q1 		$4.37M Sell
477,858
-547,964
-53% -$6.29M 0.01% 668
2019
Q4 		$14.3M Buy
1,025,822
+284,022
+38% +$4.13M 0.03% 514
2019
Q3 		$12.8M Buy
741,800
+234,022
+46% +$4.91M 0.03% 489
2019
Q2 		$13.8M Buy
507,778
+507,369
+124,051% +$11.6M 0.03% 472
2019
Q1 		$8K Sell
409
-3,324
-89% -$43.3K ﹤0.01% 1908
2018
Q4 		$35K Buy
3,733
+3,264
+696% +$41.9K ﹤0.01% 1695
2018
Q3 		$9K Sell
469
-75
-14% -$1.44K ﹤0.01% 1976
2018
Q2 		$11K Sell
544
-272
-33% -$5.38K ﹤0.01% 1898
2018
Q1 		$15K Sell
816
-1,082
-57% -$23.4K ﹤0.01% 1813
2017
Q4 		$32K Buy
+1,898
New +$32.5K ﹤0.01% 1715

Other funds holding VYGR

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Federated Hermes's VYGR Position: Q3 2025 in Review

Federated Hermes sold out of Voyager Therapeutics (VYGR) in Q3 2025, closing a stake of 317 shares — an estimated $986 sold.

Federated Hermes first reported a position in VYGR in Q4 2017 and held it in 29 quarters. The position peaked at $14.3M in Q4 2019. 117 funds tracked by Wall St. Rank hold VYGR as of Q3 2025.

  • Federated Hermes reported no remaining Voyager Therapeutics position as of Q3 2025 after selling out during the quarter.
  • Federated Hermes sold 317 Voyager Therapeutics shares in Q3 2025, an estimated $986.
  • Federated Hermes first reported a position in Voyager Therapeutics in Q4 2017 and held it in 29 quarters.
  • Federated Hermes's Voyager Therapeutics position peaked at $14.3M in Q4 2019.
  • 117 funds tracked by Wall St. Rank held Voyager Therapeutics as of Q3 2025.

Based on Federated Hermes's 13F filing for Q3 2025, filed 3 Nov 2025.